Cargando…

CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis

SIMPLE SUMMARY: Caldesmon has recently attracted attention in cancer due to its roles in cell migration, invasion and proliferation. l-CALD1 was also considered a potential serum marker for glioma. However, little is known about mechanisms underlying the effect of CALD1 on the microvascular facilita...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Quan, Tang, Anliu, Wang, Zeyu, Fang, Ning, Zhang, Zhuojing, Zhang, Liyang, Li, Chuntao, Zeng, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199308/
https://www.ncbi.nlm.nih.gov/pubmed/34070840
http://dx.doi.org/10.3390/cancers13112705
_version_ 1783707346174738432
author Cheng, Quan
Tang, Anliu
Wang, Zeyu
Fang, Ning
Zhang, Zhuojing
Zhang, Liyang
Li, Chuntao
Zeng, Yu
author_facet Cheng, Quan
Tang, Anliu
Wang, Zeyu
Fang, Ning
Zhang, Zhuojing
Zhang, Liyang
Li, Chuntao
Zeng, Yu
author_sort Cheng, Quan
collection PubMed
description SIMPLE SUMMARY: Caldesmon has recently attracted attention in cancer due to its roles in cell migration, invasion and proliferation. l-CALD1 was also considered a potential serum marker for glioma. However, little is known about mechanisms underlying the effect of CALD1 on the microvascular facilitation and architecture in glioma. The purpose of this study was to explore the role of CALD1 for prediction glioma patient prognosis and in glioma angiogenesis. The findings of this study suggested that l-CALD1 could imply abnormal microvessels in anaplastic astrocytoma and GBM. In addition, high CI (calmodulin index) predicted worse prognosis in glioma, and furthermore, CALD1 may serve as a key marker for monitoring the progress of glioma and a novel target for therapy. ABSTRACT: Angiogenesis is more prominent in anaplastic gliomas and glioblastoma (GBM) than that in pilocytic and diffuse gliomas. Caldesmon (CALD1) plays roles in cell adhesion, cytoskeletal organization, and vascularization. However, limited information is available on mechanisms underlying the effect of CALD1 on the microvascular facilitation and architecture in glioma. In this study, we explored the role of CALD1 in gliomas by integrating bulk RNA-seq analysis and single cell RNA-seq analysis. A positive correlation between CALD1 expression and the gliomas’ pathological grade was noticed, according to the samples from the TCGA and CGGA database. Moreover, higher CALD1 expression samples showed worse clinical outcomes than lower CALD1 expression samples. Biofunction prediction suggested that CALD1 may affect glioma progression through modulating tumor angiogenesis. The map of the tumor microenvironment also depicted that more stromal cells, such as endothelial cells and pericytes, infiltrated in high CALD1 expression samples. CALD1 was found to be remarkably upregulated in neoplastic cells and was involved in tumorigenic processes of gliomas in single cell sequencing analysis. Histology and immunofluorescence analysis also indicated that CALD1 associates with vessel architecture, resulting in glioma grade progression. In conclusion, the present study implies that CALD1 may serve as putative marker monitoring the progress of glioma.
format Online
Article
Text
id pubmed-8199308
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81993082021-06-14 CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis Cheng, Quan Tang, Anliu Wang, Zeyu Fang, Ning Zhang, Zhuojing Zhang, Liyang Li, Chuntao Zeng, Yu Cancers (Basel) Article SIMPLE SUMMARY: Caldesmon has recently attracted attention in cancer due to its roles in cell migration, invasion and proliferation. l-CALD1 was also considered a potential serum marker for glioma. However, little is known about mechanisms underlying the effect of CALD1 on the microvascular facilitation and architecture in glioma. The purpose of this study was to explore the role of CALD1 for prediction glioma patient prognosis and in glioma angiogenesis. The findings of this study suggested that l-CALD1 could imply abnormal microvessels in anaplastic astrocytoma and GBM. In addition, high CI (calmodulin index) predicted worse prognosis in glioma, and furthermore, CALD1 may serve as a key marker for monitoring the progress of glioma and a novel target for therapy. ABSTRACT: Angiogenesis is more prominent in anaplastic gliomas and glioblastoma (GBM) than that in pilocytic and diffuse gliomas. Caldesmon (CALD1) plays roles in cell adhesion, cytoskeletal organization, and vascularization. However, limited information is available on mechanisms underlying the effect of CALD1 on the microvascular facilitation and architecture in glioma. In this study, we explored the role of CALD1 in gliomas by integrating bulk RNA-seq analysis and single cell RNA-seq analysis. A positive correlation between CALD1 expression and the gliomas’ pathological grade was noticed, according to the samples from the TCGA and CGGA database. Moreover, higher CALD1 expression samples showed worse clinical outcomes than lower CALD1 expression samples. Biofunction prediction suggested that CALD1 may affect glioma progression through modulating tumor angiogenesis. The map of the tumor microenvironment also depicted that more stromal cells, such as endothelial cells and pericytes, infiltrated in high CALD1 expression samples. CALD1 was found to be remarkably upregulated in neoplastic cells and was involved in tumorigenic processes of gliomas in single cell sequencing analysis. Histology and immunofluorescence analysis also indicated that CALD1 associates with vessel architecture, resulting in glioma grade progression. In conclusion, the present study implies that CALD1 may serve as putative marker monitoring the progress of glioma. MDPI 2021-05-30 /pmc/articles/PMC8199308/ /pubmed/34070840 http://dx.doi.org/10.3390/cancers13112705 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cheng, Quan
Tang, Anliu
Wang, Zeyu
Fang, Ning
Zhang, Zhuojing
Zhang, Liyang
Li, Chuntao
Zeng, Yu
CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
title CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
title_full CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
title_fullStr CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
title_full_unstemmed CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
title_short CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
title_sort cald1 modulates gliomas progression via facilitating tumor angiogenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199308/
https://www.ncbi.nlm.nih.gov/pubmed/34070840
http://dx.doi.org/10.3390/cancers13112705
work_keys_str_mv AT chengquan cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis
AT tanganliu cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis
AT wangzeyu cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis
AT fangning cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis
AT zhangzhuojing cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis
AT zhangliyang cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis
AT lichuntao cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis
AT zengyu cald1modulatesgliomasprogressionviafacilitatingtumorangiogenesis